Eli Lilly CEO David Ricks comments on why it's cutting insulin prices now

Canada News News

Eli Lilly CEO David Ricks comments on why it's cutting insulin prices now
Canada Latest News,Canada Headlines
  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 63%

NPR's Ailsa Chang talks with Eli Lilly CEO David Ricks about the company's move to reduce prices on some older insulins and cap how much people have to pay out of their own pocket.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NPRHealth /  🏆 144. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Read more »

Drug Giant Eli Lilly Dramatically Slashes Price of InsulinDrug Giant Eli Lilly Dramatically Slashes Price of InsulinA hard-fought campaign to reduce the exorbitant price of insulin seems to finally be yielding some results.
Read more »

'Brilliant PR Move': Advocates Skeptical as Eli Lilly Vows 70% Insulin Price Cut'Congress, not greedy corporations trying to redeem their tarnished reputations, should be leading the way on reforms that put patients ahead of pharmaceutical profits.'
Read more »

Eli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketEli Lilly cuts the price of insulin, capping drug at $35 per month out-of-pocketThe moves announced Wednesday promise critical relief to some people with diabetes who can face annual costs of more than $1,000 for insulin they need in order to live.
Read more »

Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'Drugmaker Eli Lilly Announces 70% Price Drop In Its 'Most Commonly Prescribed Insulins'The announcement comes after waves of criticism from Americans saying the drug, which is vital to many people with diabetes, should be more accessible.
Read more »



Render Time: 2025-02-28 07:11:00